D
Aytu Biopharma, Inc. AYTU
$2.17 -$0.04-1.81% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 1.84% -19.04% -31.79% -34.46% -39.31%
Total Other Revenue -- -- -- -- --
Total Revenue 1.84% -19.04% -31.79% -34.46% -39.31%
Cost of Revenue 27.42% -22.40% -44.57% -55.63% -60.44%
Gross Profit -6.57% -17.57% -25.05% -22.12% -26.38%
SG&A Expenses -8.93% -15.90% -28.93% -37.83% -40.01%
Depreciation & Amortization 0.00% -6.92% -13.03% -18.49% -23.08%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -1.20% -17.12% -32.45% -42.57% -46.03%
Operating Income 349.03% -58.88% 46.76% 111.14% 104.58%
Income Before Tax -32.44% 130.70% 84.59% 94.09% 39.14%
Income Tax Expenses -79.60% -35.36% 90.26% -- --
Earnings from Continuing Operations -13.27% 120.00% 76.33% 83.40% 26.57%
Earnings from Discontinued Operations 118.65% 67.34% 10.23% -254.87% --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 14.40% 111.98% 70.87% 74.46% 7.08%
EBIT 349.03% -58.88% 46.76% 111.14% 104.58%
EBITDA 8.56% -34.86% -3.18% 338.39% 307.46%
EPS Basic 33.83% 107.62% 75.98% 81.48% 42.19%
Normalized Basic EPS 73.33% 194.74% 111.66% 107.36% 61.31%
EPS Diluted -9.26% 60.74% 56.43% 74.94% 42.15%
Normalized Diluted EPS 47.49% 167.93% 105.33% 104.72% 61.31%
Average Basic Shares Outstanding 13.42% 15.85% 23.76% 38.12% 64.11%
Average Diluted Shares Outstanding 47.07% 51.90% 52.29% 56.53% 64.11%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --